Biotech

All Articles

Vaccine and also Keytruda combination successful in squamous tissue carcinoma

.Immune system checkpoint preventions are the superheroes of cancer therapy. Medications like Bristo...

Cue Biopharma mark time J&ampJ vet as CBO-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of significant management hirings, shootings and...

Regeneron's Opdualag opponent presents 57% feedback fee

.Regeneron is back along with long-lasting consequence for its LAG-3 prevention and PD-1 prevention ...

AstraZeneca posts data on in-house opponents to AbbVie, Pfizer ADCs

.AstraZeneca has discussed a very early examine the functionality of its own in-house antibody-drug ...

iTeos- GSK's TIGIT star presents purposeful enhancement

.After introducing a stage 3 launch based upon beneficial midstage outcomes, iTeos as well as GSK ar...

More collective FDA may increase unusual disease R&ampD: document

.The FDA needs to be even more open and also collective to release a rise in approvals of rare condi...

Zenas, MBX, Bicara scalp to Nasdaq in warm time for biotech IPOs

.It is actually an extraordinarily hectic Friday for biotech IPOs, with Zenas BioPharma, MBX as well...

Atea's COVID antiviral fails to halt hospital stays in stage 3

.Atea Pharmaceuticals' antiviral has failed one more COVID-19 test, however the biotech still holds ...

Neurocrine's offer to save mental illness prospect neglects

.Neurocrine Biosciences' mental illness system pivot has neglected. The biotech was actually not abl...

Sanofi pays out $110M upfront for late-stage radioligand treatment

.Sanofi has created an overdue entrance to the radioligand gathering, spending one hundred million e...